Her-2/neu Overexpression Due to Polysomy 17 in Breast Cancer: Molecular Testing to Guide Therapeutic Options-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Her-2/neu Overexpression Due to Polysomy 17 in Breast Cancer: Molecular Testing to Guide Therapeutic Options

Published:2011 Issue:7 Volume:34 Page:356-360
ISSN:2296-5270
Container-title:Oncology Research and Treatment
language:en
Short-container-title:Oncol Res Treat

Author:

Sahoo Rashmita,Babu V. Chitti,Harini Vidya V.,Patil Geeta V.,Dhondalay Gopal Krishna,Kulkarni Jayashree,Nargund Ashwini R.,Rao Smitha,Venkataswamy Eswarachary,Ajaikumar Bhagya S.,Mohan Rao Raghavendra

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,Hematology

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Clinicopathologic and Prognostic Value of Altered Chromosome 17 Centromere Copy Number in HER2 Fish Equivocal Breast Carcinomas;PLOS ONE;2015-07-10

2. Chromosome 17 polysomy: correlation with histological parameters and HER2NEU gene amplification;Journal of Clinical Pathology;2013-08-01

3. HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity;Modern Pathology;2013-06-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP